These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 34845)
41. Pisa syndrome after discontinuation of clotiapine in a patient with intractable insomnia. Wang EH; Yang AC J Clin Psychopharmacol; 2014 Apr; 34(2):276-7. PubMed ID: 24525650 [No Abstract] [Full Text] [Related]
42. Parkinsonism and dyskinesias during ethanol withdrawal. Neiman J; Borg S; Wahlund LO Br J Addict; 1988 Apr; 83(4):437-9. PubMed ID: 3395725 [No Abstract] [Full Text] [Related]
43. Pentazocine abuse and problems of withdrawal. Maxmen JS; Silberfarb PM; Plakun E Br J Psychiatry; 1975 Apr; 126():370-1. PubMed ID: 238710 [No Abstract] [Full Text] [Related]
44. The mechanism of neuroleptic withdrawal. Eppel AB; Mishra R Can J Psychiatry; 1984 Oct; 29(6):508-9. PubMed ID: 6149010 [TBL] [Abstract][Full Text] [Related]
45. Off-label antipsychotic use and tardive dyskinesia in at-risk populations: new drugs with old side effects. Remington G; Hahn M J Psychiatry Neurosci; 2014 Jan; 39(1):E1-2. PubMed ID: 24359929 [No Abstract] [Full Text] [Related]
46. Neuroleptics in the elderly: guidelines for monitoring. Sweet RA; Pollock BG Harv Rev Psychiatry; 1995; 2(6):327-35. PubMed ID: 9384918 [TBL] [Abstract][Full Text] [Related]
48. Monitoring for drug-induced movement disorders. Johnson BG Nursing; 2017 May; 47(5):56-60. PubMed ID: 28445339 [No Abstract] [Full Text] [Related]
49. [Systematic neuroleptic therapy with the appearance of parkinsonian states]. FLUGEL F Encephale; 1956; 45(4):1090-2. PubMed ID: 13384343 [No Abstract] [Full Text] [Related]
50. Neuroleptics and abnormal movements. Lader MH Br Med J (Clin Res Ed); 1982 Aug; 285(6340):463-4. PubMed ID: 6125232 [No Abstract] [Full Text] [Related]
51. Dyskinesia, antipsychotic-drug exposure and risk factors in a developmentally-disabled population. Stone RK; Alvarez WF; May JE Pharmacol Biochem Behav; 1988 Jan; 29(1):45-51. PubMed ID: 2451256 [TBL] [Abstract][Full Text] [Related]
52. Dystonia as a presenting feature of alcohol withdrawal. Bijjal S; Subodh BN; Narayanaswamy JC; Chand P; Benegal V; Murthy P J Neuropsychiatry Clin Neurosci; 2012; 24(1):E15-6. PubMed ID: 22450628 [No Abstract] [Full Text] [Related]
53. Maintenance antipsychotic trials and the effect of withdrawal. Munkholm K; Horowitz MA; Moncrieff J Lancet; 2022 Sep; 400(10357):995. PubMed ID: 36154688 [No Abstract] [Full Text] [Related]
54. Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment. Connor DF; Benjamin S; Ozbayrak KR J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1490-4. PubMed ID: 8543517 [TBL] [Abstract][Full Text] [Related]
58. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal. Thomas A; Onofrj M Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099 [No Abstract] [Full Text] [Related]